文献速递遗传性与小管间质肾病慢性肾脏病血液净化与透析

原发性高草酸尿症3型也可导致肾衰竭:一例病例报告

Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report.
PubMed 文献 · Am J Kidney Dis · 2021-07-07

本文报告一例33岁男性,儿童期反复泌尿系结石及严重高草酸尿症,29岁时CKD 4期(eGFR 24mL/min/1.73m2),33岁开始每周3次血液透析,基因检测发现HOGA1纯合突变(C.973G>A p.Gly325Ser)确诊PH3。提示儿童期反复结石伴显著高草酸尿症应行已知3种PH型别基因检测。

要点

  • 儿童期反复泌尿系结石伴显著高草酸尿症应行PH1-3基因检测。
  • PH3虽罕见但可进展至肾衰竭,需长期随访肾功能。
  • 充分水化与柠檬酸盐结晶抑制剂是标准治疗,RNA干扰药物在研。

核心结论

  • PH3可导致肾衰竭,儿童期反复结石伴显著高草酸尿症应行基因检测明确分型。

研究设计与样本

  • 单例病例报告:33岁男性,儿童期起反复泌尿系结石及严重高草酸尿,29岁CKD 4期(eGFR 24mL/min/1.73m2),33岁开始每周3次血液透析,经基因检测确诊PH3。

主要发现

  • 患者12岁出现膀胱结石及双侧鹿角形结石,多次代谢评估显示高草酸尿症伴极低尿柠檬酸排泄。
  • 29岁时CKD 4期,eGFR 24mL/min/1.73m2;33岁开始每周3次血液透析。
  • 基因检测发现HOGA1纯合突变(C.973G>A p.Gly325Ser),诊断PH3。
  • 既往文献报告PH3肾衰竭仅2例,本例为新增病例。

关键数值与推荐

  • PH3由HOGA1基因突变所致,本例突变为C.973G>A p.Gly325Ser纯合突变。
  • 儿童期反复泌尿系结石伴显著高草酸尿症应行3种已知PH型别基因检测。
  • 充分水化及柠檬酸盐等结晶抑制剂为PH标准治疗。
  • RNA干扰药物对3种PH型别的治疗作用正在研究中。

临床怎么用

  • 对儿童期反复结石伴显著高草酸尿症患者应尽早行PH1-3基因检测,避免漏诊PH3。
  • 确诊PH3后需监测肾功能,进展至肾衰竭时评估透析及肝肾移植等治疗选择。

局限性

  • 为单例病例报告,不能推断PH3肾衰竭的发生率或预后。
  • 患者曾失访,代谢评估未完善,部分临床信息不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary hyperoxaluria (PH) is a group of genetic disorders that result in an increased hepatic production of oxalate. PH type 3 (PH3) is the most recently identified subtype and results from mutations in the mitochondrial 4-hydroxy-2-oxoglutarate aldolase gene (HOGA1). To date, there have been 2 cases of kidney failure reported in PH3 patients. We present a case of a young man with a history of recurrent urinary tract infections and voiding dysfunction who developed kidney failure at 33 years of age. He developed a bladder stone and bilateral staghorn calculi at 12 years of age. Initial metabolic evaluation revealed hyperoxaluria with very low urinary citrate excretion on multiple measurements for which he was placed on oral citrate supplements. Further investigation of the hyperoxaluria was not completed as the patient was lost to follow-up observation until he presented at 29 years of age with chronic kidney disease stage 4 (estimated glomerular filtration rate 24mL/min/1.73m2). Hemodialysis 3 times a week was started at 33 years of age, and subsequent genetic testing revealed a homozygous HOGA1 mutation (C.973G>A p.Gly325Ser) diagnostic of PH3. The patient is currently being evaluated for all treatment options including possible liver/kidney transplantation. All cases of a childhood history of recurrent urinary stone disease with marked hyperoxaluria should prompt genetic testing for the 3 known PH types. Hyperhydration and crystallization inhibitors (citrate) are standard of care, but the role of RNA interference agents for all 3 forms of PH is also under active study.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Singh P, Granberg CF, Harris PC, et al. Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report. Am J Kidney Dis. 2021. PMID: 34245816. doi:10.1053/j.ajkd.2021.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。